Works by Ik-Joo Chung

Results: 113
    1

    The combined evaluation of interim contrast-enhanced computerized tomography (CT) and FDG-PET/CT predicts the clinical outcomes and may impact on the therapeutic plans in patients with aggressive non-Hodgkin's lymphoma.

    Published in:
    2009
    By:
    • Deok-Hwan Yang;
    • Jung-Joon Min;
    • Yong Jeong;
    • Jae-Sook Ahn;
    • Yeo-Kyeoung Kim;
    • Sang-Hee Cho;
    • Ik-Joo Chung;
    • Hee-Seung Bom;
    • Hyeoung-Joon Kim;
    • Je-Jung Lee;
    • Yang, Deok-Hwan;
    • Min, Jung-Joon;
    • Jeong, Yong Yeon;
    • Ahn, Jae-Sook;
    • Kim, Yeo-Kyeoung;
    • Cho, Sang-Hee;
    • Chung, Ik-Joo;
    • Bom, Hee-Seung;
    • Kim, Hyeoung-Joon;
    • Lee, Je-Jung
    Publication type:
    journal article
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20

    Prognostic implications of thymidylate synthase gene polymorphisms in patients with advanced small bowel adenocarcinoma treated with first-line fluoropyrimidine-based chemotherapy.

    Published in:
    Oncology Reports, 2015, v. 34, n. 1, p. 155, doi. 10.3892/or.2015.3954
    By:
    • HO-YOUNG YHIM;
    • SANG-HEE CHO;
    • SAM YONG KIM;
    • IN SUNG CHO;
    • KYU TAEK LEE;
    • WON SUP LEE;
    • SOON IL LEE;
    • MOO RIM PARK;
    • SANG-GON PARK;
    • HYE-SUK HAN;
    • YOON SEOK CHOI;
    • IK-JOO CHUNG;
    • HYUN-JEONG SHIM;
    • NA-RI LEE;
    • EUN-KEE SONG;
    • HEE SUN KIM;
    • CHANG-YEOL YIM
    Publication type:
    Article
    21
    22

    Efficacy, Tolerability, and Biomarker Analyses of Once-Every-2-Weeks Cetuximab Plus First-Line FOLFOX or FOLFIRI in Patients With KRAS or All RAS Wild-Type Metastatic Colorectal Cancer: The Phase 2 APEC Study.

    Published in:
    2017
    By:
    • Ann-Lii Cheng;
    • Cornelio, Gerardo;
    • Lin Shen;
    • Price, Timothy;
    • Tsai-Sheng Yang;
    • Ik Joo Chung;
    • Guang-Hai Dai;
    • Jen-Kou Lin;
    • Sharma, Atul;
    • Kun-Huei Yeh;
    • Brigette Ma;
    • Zaatar, Adel;
    • Zhongzhen Guan;
    • Masood, Nehal;
    • Srimuninnimit, Vichien;
    • Thomas Yau;
    • Gibbs, Peter;
    • Xiuwen Wang;
    • Doval, Dinesh Chandra;
    • Seung-Taek Oh
    Publication type:
    journal article
    23

    Combination of percutaneous radiofrequency ablation and systemic chemotherapy are effective treatment modalities for metachronous liver metastases from gastric cancer.

    Published in:
    Clinical & Experimental Metastasis, 2014, v. 31, n. 1, p. 25, doi. 10.1007/s10585-013-9606-5
    By:
    • Hwang, Jun-Eul;
    • Kim, Seung-Hun;
    • Jin, Joon;
    • Hong, Ji-Yun;
    • Kim, Min-Jee;
    • Jung, Sung-Hoon;
    • Shim, Hyun-Jeong;
    • Bae, Woo-kyun;
    • Hwang, Eu-Chang;
    • Kim, Jin-Woong;
    • Shin, Sang-Soo;
    • Jeong, Oh;
    • Park, Young;
    • Cho, Sang-Hee;
    • Chung, Ik-Joo
    Publication type:
    Article
    24

    Rapidly progressing primary splenic angiosarcoma with fatal hemorrhagic event.

    Published in:
    Journal of Chemotherapy (Taylor & Francis Ltd), 2014, v. 26, n. 4, p. 248, doi. 10.1179/1973947813Y.0000000146
    By:
    • Cho, Eun Ae;
    • Choi, Won-Young;
    • Kim, Seung-Hun;
    • Hong, Ji-Yun;
    • Jung, Sung-Hoon;
    • Kim, Min-Jee;
    • Hwang, Jun-Eul;
    • Bae, Woo-Kyun;
    • Shim, Hyun-Jeong;
    • Lee, Kyung-Hwa;
    • Cho, Sang-Hee;
    • Chung, Ik-Joo
    Publication type:
    Article
    25
    26
    27
    28
    29
    30
    31

    Successful cross-presentation of allogeneic myeloma cells by autologous alpha-type 1-polarized dendritic cells as an effective tumor antigen in myeloma patients with matched monoclonal immunoglobulins.

    Published in:
    Annals of Hematology, 2011, v. 90, n. 12, p. 1419, doi. 10.1007/s00277-011-1219-y
    By:
    • Yang, Deok-Hwan;
    • Kim, Mi-Hyun;
    • Lee, Youn-Kyung;
    • Hong, Cheol;
    • Lee, Hyun;
    • Nguyen-Pham, Thanh-Nhan;
    • Bae, Soo;
    • Ahn, Jae-Sook;
    • Kim, Yeo-Kyeoung;
    • Chung, Ik-Joo;
    • Kim, Hyeoung-Joon;
    • Kalinski, Pawel;
    • Lee, Je-Jung
    Publication type:
    Article
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42

    Fibroblast growth factor receptor 4 increases epidermal growth factor receptor (EGFR) signaling by inducing amphiregulin expression and attenuates response to EGFR inhibitors in colon cancer.

    Published in:
    Cancer Science, 2020, v. 111, n. 9, p. 3268, doi. 10.1111/cas.14526
    By:
    • Hong, Chang‐Soo;
    • Sun, Eun‐Gene;
    • Choi, Ji‐Na;
    • Kim, Dae‐Hwan;
    • Kim, Jo‐Heon;
    • Ryu, Kyung‐Hyun;
    • Shim, Hyun‐Jeong;
    • Hwang, Jun‐Eul;
    • Bae, Woo‐Kyun;
    • Kim, Hyeong‐Rok;
    • Kim, Kyung Keun;
    • Jung, Chaeyong;
    • Chung, Ik‐Joo;
    • Cho, Sang‐Hee
    Publication type:
    Article
    43
    44

    Nivolumab plus chemotherapy in patients with HER2-negative, previously untreated, unresectable, advanced, or recurrent gastric/gastroesophageal junction cancer: 3-year follow-up of the ATTRACTION-4 randomized, double-blind, placebo-controlled, phase 3 trial

    Published in:
    Gastric Cancer, 2024, v. 27, n. 6, p. 1287, doi. 10.1007/s10120-024-01535-0
    By:
    • Boku, Narikazu;
    • Omori, Takeshi;
    • Shitara, Kohei;
    • Sakuramoto, Shinichi;
    • Yamaguchi, Kensei;
    • Kato, Ken;
    • Kadowaki, Shigenori;
    • Tsuji, Kunihiro;
    • Ryu, Min-Hee;
    • Oh, Do-Youn;
    • Oh, Sang Cheul;
    • Rha, Sun Young;
    • Lee, Keun-Wook;
    • Chung, Ik-Joo;
    • Sym, Sun Jin;
    • Chen, Li-Tzong;
    • Chen, Jen-Shi;
    • Bai, Li-Yuan;
    • Nakada, Takashi;
    • Hagihara, Shunsuke
    Publication type:
    Article
    45
    46
    47
    48
    49
    50